David Béchard

Gründer bei Cytune Pharma SAS

Health Technology

Commercial Services

Consumer Services

Aktive Positionen von David Béchard

Unternehmen	Position	Beginn	Ende
Cytune Pharma SAS Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France.	Vorsitzender	18.12.2007	-
	Gründer	15.11.2007	-
	Geschäftsführer	15.11.2007	-
	Präsident	15.11.2007	-

Unternehmen	Position	Beginn	Ende
Atlanpole Biotherapy	Corporate Officer/Principal	-	-
Endotis Pharma SARL Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Endotis Pharma SARL is a holding company, which is engaged in the development of differentiated cardiovascular therapeutics based on validated targets and modes of action. The company was founded in 2003 and it is headquartered in Romainville, France.	Vorsitzender	01.02.2003	-
	Gründer	01.02.2003	-
	Präsident	01.02.2003	-

École des Hautes Études Commerciales de Paris

Graduate Degree

International

Frankreich

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	3
Endotis Pharma SARL Endotis Pharma SARL Pharmaceuticals: MajorHealth Technology Endotis Pharma SARL is a holding company, which is engaged in the development of differentiated cardiovascular therapeutics based on validated targets and modes of action. The company was founded in 2003 and it is headquartered in Romainville, France.	Health Technology
Cytune Pharma SAS Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France.	Commercial Services
Atlanpole Biotherapy